Diapulse Corp America> receive permission resume marketing Diapulse pulse peak electromagnetic energy medical device treatment postoperative edema pain superficial soft tissues. The company enjoin marketing product U.S. 1972 due label impasse U.S. Food Drug Administration. It U.S. District Court Eastern District New York modify injunction sale product follow motion file jointly company FDA. Reuter 